Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
05/2010
05/27/2010US20100130550 Ocular formulations of norketotifen
05/27/2010US20100130546 Quinolone compound and pharmaceutical composition
05/27/2010US20100130504 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2010US20100130448 3',4',5-trimethoxy flavone derivatives as stimulatn of mucus secretion, method for the same, and pharmaceutical composition comprising the same
05/27/2010US20100130444 Complexes of prostaglandin derivatives and monosubstituted, charged beta-cyclodextrins
05/27/2010US20100130413 Treatment for age-related macular degeneration and other diseases of the eye
05/27/2010US20100129467 Nutritional supplement
05/27/2010US20100129435 Methods and compositions for treatment of ocular neovascularization and neural injury
05/27/2010US20100129417 Dihydroxybenzoate Polymers and Uses Thereof
05/27/2010US20100129375 Methods for inhibiting ocular angiogenesis
05/27/2010US20100129373 Vegf-specific human antibody
05/27/2010US20100129364 Combination therapy for the treatment of ocular neovascular disorders
05/27/2010US20100129355 Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient
05/27/2010US20100129327 Method of treating hearing loss
05/27/2010US20100129316 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
05/27/2010CA2743782A1 Therapeutic agent for chorioretinal degenerative disease containing pyridine-3-carbaldehyde o-(piperidin-1-yl-propyl)-oxime derivative as active ingredient
05/27/2010CA2743436A1 Pathways to generate hair cells
05/27/2010CA2742947A1 Antioxidant
05/27/2010CA2742946A1 Antioxidant
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189157A1 EYE DROP COMPRISING DIBENZO[b,e]OXEPIN DERIVATIVE
05/26/2010EP2187901A2 Therapeutic use of neuropeptide ei and a acth 7-38 and compositions thereof
05/26/2010EP2187900A2 Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
05/26/2010EP2187743A2 Formulations for treatment of ocular diseases or conditions
05/26/2010EP1539137B1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010CN1922183B Nitrogenous fused heteroaromatic ring derivative
05/26/2010CN1893932B Microemulsion preconcentrate comprising a renin inhibitor
05/26/2010CN1831119B Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
05/26/2010CN1799559B Chinese medicinal gel formulation, its preparation process and quality control method
05/26/2010CN1799557B Chinese medicinal gel formulation, its preparation process and quality control method
05/26/2010CN1726993B Ophthalmic preparation of fresh dendrobium stem, and preparation method
05/26/2010CN1690057B Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
05/26/2010CN1655823B Topically applicable pharmaceutical preparation
05/26/2010CN1496270B Pharmaceutical composition based on macrolides for topical application in ophthalmology
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101712649A Lotus leaf extract, monomer component and application thereof
05/26/2010CN101711863A Vaccine eye drops used for treating and preventing glaucoma and preparation method
05/26/2010CN101711784A Preparation method of serissa serissoide extractive
05/26/2010CN101711745A Intraocular nano particle freeze-dried powders and preparation method thereof
05/26/2010CN101711737A Agents for intravitreal administration to treat or prevent disorders of the eye
05/25/2010US7723505 EAAT2 promoter and uses thereof
05/25/2010US7723480 Leucine-based motif and clostridial neurotoxins
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723324 Treating anxiety and insomnia; drugs facilitate the inhibitory action of the neurotransmitter GABA; 2-(6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-1-thiophen-2-yl-ethanone for example
05/25/2010US7723293 administering to the heart of subject in need of increased capillary density in the heart a trk receptor ligand in an amount effective to increase capillary density in the heart, said trk receptor ligand being selected from the group consisting of brain-derived neurotrophic factor, NT-3, and NT-4.
05/25/2010CA2584975C Drug and food or drink for improving pancreatic functions
05/25/2010CA2489337C Indole derivatives useful as histamine h3 antagonists
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2434961C L-histidine in ophthalmic solutions
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2395461C Methods of modulating c-kit tyrosine kinase function with indolinone compounds
05/20/2010WO2010057028A2 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010WO2010056985A2 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010WO2010056598A2 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010017541A3 Compositions and methods for treatment of neurodegenerative disease
05/20/2010WO2010011466A3 Controlled-release cns modulating compositions and methods for the treatment of otic disorders
05/20/2010US20100125077 Polymorphs of Brimonidine Pamoate
05/20/2010US20100125076 Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
05/20/2010US20100124565 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
05/20/2010CA2743837A1 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
05/20/2010CA2743709A1 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/19/2010EP2186529A2 Synergic pharmaceutical composition, useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animal
05/19/2010EP2186528A1 Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor
05/19/2010EP2185558A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same
05/19/2010EP2185521A2 Compounds and methods for modulating rho gtpases
05/19/2010EP2185181A2 Therapeutic uses of gastrin-1 and g-pen-grgdspca
05/19/2010EP1467995B1 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
05/19/2010EP1371646B1 Aryl-substituted alicyclic compound and medical composition comprising the same
05/19/2010CN101708313A Pharmaceutical composition for promoting blood circulation and removing obstruction in channels
05/19/2010CN101708167A Intraocular nano-particle frozen-dried powder and method for preparing same
05/19/2010CN101708165A Microspheres for active embolization
05/19/2010CN101194983B Dropping pills for treating sudden deafness and method for preparing the same
05/19/2010CN101130083B Ophthalmic composition, producing method and use of the same
05/19/2010CN101129698B Eye drops containing turmeric extractive and preparation method thereof
05/19/2010CN101121012B Traditional Chinese medicine for treating external oculopathy eye disease
05/19/2010CN101085174B Traditional Chinese medicine oral liquid with kidney-nourishing eyesight-improving and health-care function
05/19/2010CN101029338B Determination of risk factors for cataract by aldose reductase genotype
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718701 Prostaglandin, e.g., 1R,2R,3R,5R)-5-halo-2-[(1E,3S)-3-cycloalkyl-3-hydroxy-1-propenyl]-3-hydroxycyclopentyl]-(5Z)-5-alkenoic acids; treating in particular, symptoms of atopic dermatitis
05/18/2010US7718387 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2383357C Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues
05/18/2010CA2355716C Benzisoxazoles and phenones as .alpha.2-antagonists
05/18/2010CA2284041C Indolecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
05/14/2010WO2010053101A1 Eye drop having high intraocular migration properties, fluorescent imaging agent, and methods for producing same
05/14/2010WO2010052896A1 Preparation for local administration containing fluticasone propionate
05/14/2010WO2010011605A3 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
05/13/2010US20100120908 Eye drop preparation comprising latanoprost
05/13/2010US20100120904 Novel use of genistein
05/13/2010US20100120883 Novel compounds
05/13/2010US20100120873 Prophylactic or therapeutic agent for age-related macular degeneration
05/13/2010US20100120865 thiazol-2-yl-urea derivatives such as 3-{3-[4-Methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-N-pyridin-3-yl-propionamide, used in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase, particularly inflammatory, allergic or autoimmune conditions
05/13/2010US20100120807 Compounds and compositions as modulators of gpr119 activity
05/13/2010US20100120766 Substituted Pteridines
05/13/2010US20100120665 Treatment of diseases characterized by inflammation
1 ... 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 ... 531